Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 12.42 USD 4.99% Market Closed
Market Cap: 1.6B USD

Wall Street
Price Targets

NEO Price Targets Summary
Neogenomics Inc

Wall Street analysts forecast NEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEO is 13.03 USD with a low forecast of 5.05 USD and a high forecast of 17.85 USD.

Lowest
Price Target
5.05 USD
59% Downside
Average
Price Target
13.03 USD
5% Upside
Highest
Price Target
17.85 USD
44% Upside
Neogenomics Inc Competitors:
Price Targets
ONT
Oxford Nanopore Technologies PLC
61% Upside
TMO
Thermo Fisher Scientific Inc
12% Upside
MRVI
Maravai LifeSciences Holdings Inc
12% Upside
ABSI
Absci Corp
129% Upside
FTRE
Fortrea Holdings Inc
24% Downside
DIVISLAB
Divi's Laboratories Ltd
6% Upside
SHC
Sotera Health Co
12% Upside
DIM
Sartorius Stedim Biotech SA
19% Upside

Revenue
Forecast

Revenue Estimate
Neogenomics Inc

For the last 13 years the compound annual growth rate for Neogenomics Inc's revenue is 23%. The projected CAGR for the next 4 years is 10%.

23%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Neogenomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Neogenomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NEO's stock price target?
Price Target
13.03 USD

According to Wall Street analysts, the average 1-year price target for NEO is 13.03 USD with a low forecast of 5.05 USD and a high forecast of 17.85 USD.

What is Neogenomics Inc's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Neogenomics Inc's revenue is 23%. The projected CAGR for the next 4 years is 10%.

Back to Top